Recruiting studies: Solid Tumors Harboring Ntrk Fusion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · 76 location(s) · Bayer · NCT04142437 A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTR
Phase 1/Phase 2 · 6 location(s) · Cullgen (Shanghai),Inc · NCT07394374 NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Phase N/A · 1 location(s) · Bayer · NCT04945330 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Phase 1/Phase 2 · 1 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT05745623 A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
Phase 2 · 19 location(s) · Teligene US · NCT06010342

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.